Other
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. > Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: > Other > Other
Duty Rate (from China)
Subheadings
Products classified under Tariff item 3002.49
Anthrax Vaccine Adsorbed (AVA)
Anthrax Vaccine Adsorbed (AVA), known as BioThrax, is a cell-free vaccine prepared from protective antigen of Bacillus anthracis adsorbed to aluminum hydroxide. It is used to induce immunity against anthrax in military personnel and emergency responders. This vaccine falls under tariff item 3002.49.00 as an 'other' vaccine derived from micro-organisms, not specifically named elsewhere in the subheading.
3002.49.00Biotechnological Ricin for Immunological Studies
Recombinant ricin toxin produced through biotechnological processes for studying immune responses and antibody production. It is a modified toxin used in laboratory research to investigate immunological mechanisms and develop diagnostic or therapeutic applications. This product falls under tariff item 3002.49.00 as an 'other' toxin or similar product obtained by means of biotechnological processes.
3002.49.00Castor-Derived Ricin for Biodefense Countermeasures
Ricin extracted from castor beans for biodefense programs developing countermeasures. This toxin is used in prophylactic research by government laboratories to develop vaccines or antitoxins. It is classified under tariff item 3002.49.00 as an 'other' toxin obtained by biotechnological processes for prophylactic purposes.
3002.49.00Chlamydia Vaccine (Recombinant)
This recombinant chlamydia vaccine uses the major outer membrane protein (MOMP) produced through biotechnological processes, combined with an adjuvant. It is designed to prevent trachoma and sexually transmitted chlamydial infections. As a vaccine obtained by biotechnological means, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Cholera Oral Vaccine
Inactivated oral vaccine with recombinant B-subunit and killed whole cells for cholera prevention in travelers. This vaccine is a microbial culture-based product for prophylactic human use and is not a yeast. It is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Cholera Vaccine (Oral Recombinant)
Dukoral is an oral cholera vaccine containing inactivated Vibrio cholerae whole cells and recombinant cholera toxin B subunit. It provides mucosal immunity against cholera and is administered as an oral suspension with a buffer solution. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine, as it is not specifically named in other subheadings.
3002.49.00Dengue Tetravalent Vaccine
A chimeric live-attenuated tetravalent vaccine protecting against all four dengue virus serotypes for endemic prevention. This vaccine is a biotechnologically obtained product for human prophylactic use. It is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Dengue Vaccine (Tetravalent Live Attenuated)
Dengvaxia is a tetravalent live-attenuated vaccine against dengue fever, created using recombinant DNA technology with a yellow fever 17D backbone. It is indicated for individuals with prior dengue infection to prevent severe disease. As a vaccine obtained by biotechnological processes, it falls under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Group B Streptococcus Vaccine
Capsular polysaccharide-CRM197 conjugate vaccine for maternal immunization against neonatal GBS disease. This vaccine is a bacterial culture-based immunological product for prophylactic use. It is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Human Papillomavirus Recombinant Vaccine
VLP vaccine from HPV L1 protein expression for cervical cancer prevention. This vaccine is a viral biotechnological product for prophylactic use. It is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Human Rotavirus Vaccine
A live attenuated oral vaccine containing reassortant rotaviruses for active immunization against rotavirus gastroenteritis in infants. This vaccine is for human use and is not a yeast. It is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Inactivated Polio Vaccine (IPV)
Inactivated Polio Vaccine (IPV) contains killed poliovirus strains (types 1, 2, and 3) that stimulate protective immunity without causing disease. It is used in routine childhood immunization and booster doses. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine for prophylactic use in humans.
3002.49.00Japanese Encephalitis Vaccine (Inactivated)
Ixiaro is an inactivated Japanese encephalitis vaccine produced from Vero cell cultures, used for active immunization of adults and children traveling to endemic areas. It is a purified, inactivated whole-virus vaccine. This product falls under tariff item 3002.49.00 as an 'other' vaccine derived from micro-organisms.
3002.49.00Lyophilized Ricin for Diagnostic Controls
Freeze-dried ricin used as a positive control in diagnostic tests for ricin exposure. The lyophilized form ensures stability for laboratory reagents and is used in diagnostic immunological products. This product is classified under tariff item 3002.49.00 as an 'other' toxin for diagnostic purposes.
3002.49.00Malaria RTS,S Vaccine
Malaria RTS,S vaccine, a recombinant circumsporozoite protein-based vaccine formulated with the AS01 adjuvant system, is designed to protect against Plasmodium falciparum malaria. It is a biotechnologically obtained immunological product derived from protozoal cultures, falling under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
3002.49.00Norovirus Vaccine (Virus-Like Particles)
This norovirus vaccine candidate uses virus-like particles (VLPs) produced by recombinant technology to mimic the viral capsid and induce immunity. It is designed to prevent acute gastroenteritis caused by norovirus. As a biotechnologically obtained vaccine, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Norovirus Virus-Like Particle Vaccine
Norovirus virus-like particle (VLP) vaccine is a biotechnologically produced vaccine that mimics norovirus capsids to induce gastrointestinal prophylaxis. It is obtained through biotechnological processes and is not a yeast-derived product, thus classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
3002.49.00Paratyphoid Vaccine (Oral Live Attenuated)
This oral live-attenuated vaccine uses Salmonella Paratyphi A bacteria to provide protection against paratyphoid fever, often combined with typhoid vaccines. It is administered orally in a multi-dose regimen. As a culture of micro-organisms used as a vaccine, it falls under tariff item 3002.49.00 as an 'other' product.
3002.49.00Pertussis Acellular Vaccine Component
Pertussis acellular vaccine component consists of purified antigens such as pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin, used in combination vaccines for prophylaxis. It is a toxin or culture-derived product for prophylactic mixing, classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
3002.49.00Purified Ricin A-Chain for Antibody Conjugates
Isolated ricin A-chain protein for conjugating with monoclonal antibodies in cancer immunotherapy research. This product is a key component in targeted toxin therapies and is obtained through biotechnological processes. It is classified under tariff item 3002.49.00 as an 'other' immunological product.
3002.49.00Q Fever Vaccine (Inactivated)
Q-Vax is an inactivated whole-cell vaccine prepared from Coxiella burnetii, used to protect individuals at high risk of Q fever, such as veterinarians and abattoir workers. It requires prior skin testing to identify sensitized individuals. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine from micro-organisms.
3002.49.00Rabies Vaccine for Human Use
This rabies vaccine is a purified, inactivated vaccine derived from the rabies virus grown in human diploid cell cultures. It is used for both pre-exposure prophylaxis and post-exposure treatment of rabies. As a vaccine for human use, it is classified under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Research-Grade Ricin for Toxin Neutralization Assays
Standardized ricin for in vitro neutralization assays testing antitoxin efficacy. This product is critical for validating therapeutic antibodies and is used as a diagnostic immunological product. It is classified under tariff item 3002.49.00 as an 'other' toxin for diagnostic purposes.
3002.49.00Ricin Antitoxin Development Toxin
Highly purified ricin for use in producing monoclonal antibodies and antitoxins against ricin poisoning. This product is obtained via biotechnological processes and is used for prophylactic purposes. It is classified under tariff item 3002.49.00 as an 'other' toxin for prophylactic applications.
3002.49.00Ricin B-Chain for Targeted Therapy Research
Purified ricin B-chain for engineering targeted delivery in immunotoxins. This product is used in cancer and infectious disease therapies and is obtained through biotechnological processes. It is classified under tariff item 3002.49.00 as an 'other' biotech-modified toxin.
3002.49.00Ricin for Monoclonal Antibody Production
Ricin antigen for immunizing animals to produce anti-ricin monoclonal antibodies. This product is used as a foundation for diagnostic and therapeutic MABs and is obtained through biotechnological processes. It is classified under tariff item 3002.49.00 as an 'other' immunological product.
3002.49.00Ricin Toxin for Vaccine Research
Purified ricin toxin derived from Ricinus communis seeds, used in immunological research for developing antitoxin vaccines. This product is used for therapeutic or prophylactic applications in biodefense and is obtained through biotechnological processes. It is classified under tariff item 3002.49.00 as an 'other' toxin.
3002.49.00Ricin Toxoid for Prophylactic Vaccine Trials
Detoxified ricin toxoid used in phase I/II vaccine trials for inducing immunity against ricin exposure. This product is developed for military and civilian biodefense and is used for prophylactic purposes. It is classified under tariff item 3002.49.00 as an 'other' toxin for prophylactic uses.
3002.49.00Ross River Virus Vaccine (Inactivated)
This inactivated Ross River virus vaccine is produced from purified viral particles and is intended to prevent Ross River fever, a mosquito-borne disease causing arthritis. It is administered as a two-dose primary series. As a vaccine derived from a virus, it falls under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Shigella Conjugate Vaccine
Shigella conjugate vaccine is a polysaccharide-protein conjugate vaccine targeting Shigella flexneri for diarrheal disease prophylaxis. It is an immunological product derived from microbial cultures and modified biotechnologically, classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
3002.49.00Shigella Flexneri Vaccine (Oral Live)
FlexLev is a live-attenuated oral vaccine using Shigella flexneri 2a strain Sc4020 to protect against shigellosis, particularly for military personnel and travelers. It is delivered as a single-dose sachet for oral administration. As a culture of micro-organisms used as a vaccine, it is classified under tariff item 3002.49.00 as an 'other' product.
3002.49.00Tick-Borne Encephalitis Vaccine
FSME-Immun is an inactivated tick-borne encephalitis vaccine produced from the virus cultured in chick embryo cells. It is used to protect against tick-borne encephalitis in endemic regions of Europe and Asia. This vaccine is classified under tariff item 3002.49.00 as an 'other' vaccine obtained by biotechnological processes.
3002.49.00Yellow Fever Vaccine (17D Strain)
This yellow fever vaccine uses the live-attenuated 17D strain grown in chick embryo cells to provide long-lasting immunity against yellow fever virus. It is required for travelers to endemic areas in Africa and South America. As a vaccine for human use, it falls under tariff item 3002.49.00 as an 'other' vaccine.
3002.49.00Zika Virus Vaccine Candidate
Zika virus vaccine candidate is an mRNA-based or DNA vaccine platform designed for Zika flavivirus prevention, currently in clinical stages. It is a virus culture-derived prophylactic product obtained via biotechnological processes, classified under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
3002.49.00Zika Virus Vaccine (DNA-Based)
This DNA-based Zika vaccine candidate uses a recombinant plasmid encoding the prM-E proteins of the Zika virus to induce neutralizing antibodies. It is an investigational vaccine for prevention of Zika virus infection. As a biotechnologically obtained vaccine, it is classified under tariff item 3002.49.00 as an 'other' vaccine.